These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 33780152)

  • 1. Polymorphism of genes involved in methotrexate pathway: Predictors of response to methotrexate therapy in Indian rheumatoid arthritis patients.
    Singh A; Gangadharan H; Gupta V; Patro PS; Misra R; Aggarwal A
    Int J Rheum Dis; 2021 May; 24(5):654-662. PubMed ID: 33780152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the ATIC 347 C/G polymorphism with responsiveness to and toxicity of methotrexate in rheumatoid arthritis: a meta-analysis.
    Lee YH; Bae SC
    Rheumatol Int; 2016 Nov; 36(11):1591-1599. PubMed ID: 27379764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent-onset rheumatoid arthritis.
    Wessels JA; van der Kooij SM; le Cessie S; Kievit W; Barerra P; Allaart CF; Huizinga TW; Guchelaar HJ;
    Arthritis Rheum; 2007 Jun; 56(6):1765-75. PubMed ID: 17530705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of dihydrofolate reductase (DHFR) -317AA genotype with poor response to methotrexate in patients with rheumatoid arthritis.
    Milic V; Jekic B; Lukovic L; Bunjevacki V; Milasin J; Novakovic I; Damnjanovic T; Popovic B; Maksimovic N; Damjanov N; Radunovic G; Pejnovic N; Krajinovic M
    Clin Exp Rheumatol; 2012; 30(2):178-83. PubMed ID: 22324981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of candidate polymorphisms and disease activity in rheumatoid arthritis patients on methotrexate.
    Lee YC; Cui J; Costenbader KH; Shadick NA; Weinblatt ME; Karlson EW
    Rheumatology (Oxford); 2009 Jun; 48(6):613-7. PubMed ID: 19193698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATIC 347C>G gene polymorphism may be associated with methotrexate-induced adverse events in south Indian Tamil rheumatoid arthritis.
    Muralidharan N; Mariaselvam CM; Jain VK; Gulati R; Negi VS
    Pharmacogenomics; 2016 Feb; 17(3):241-8. PubMed ID: 26799664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Aminoimidazole-4-carboxamide ribonucleotide-transformylase and inosine-triphosphate-pyrophosphatase genes variants predict remission rate during methotrexate therapy in patients with juvenile idiopathic arthritis.
    Pastore S; Stocco G; Moressa V; Zandonà L; Favretto D; Malusà N; Decorti G; Lepore L; Ventura A
    Rheumatol Int; 2015 Apr; 35(4):619-27. PubMed ID: 25240429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATIC missense variant affects response to methotrexate treatment in rheumatoid arthritis patients.
    Kurzawski M; Malinowski D; Szarmach N; Nowak A; Goryniak A; Pawlik A; Droździk M
    Pharmacogenomics; 2016 Dec; 17(18):1971-1978. PubMed ID: 27885916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the 5-aminoimidazole-4-carboxamide ribonucleotide transformylase gene with response to methotrexate in juvenile idiopathic arthritis.
    Hinks A; Moncrieffe H; Martin P; Ursu S; Lal S; Kassoumeri L; Weiler T; Glass DN; Thompson SD; Wedderburn LR; Thomson W
    Ann Rheum Dis; 2011 Aug; 70(8):1395-400. PubMed ID: 21515602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of a clinical pharmacogenetic model to predict methotrexate nonresponse in rheumatoid arthritis patients.
    Eektimmerman F; Allaart CF; Hazes JM; Madhar MB; den Broeder AA; Fransen J; Swen JJ; Guchelaar HJ
    Pharmacogenomics; 2019 Jan; 20(2):85-93. PubMed ID: 30628539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purine biosynthetic pathway genes and methotrexate response in rheumatoid arthritis patients among north Indians.
    Sharma S; Das M; Kumar A; Marwaha V; Shankar S; Singh P; Raghu P; Aneja R; Grover R; Arya V; Dhir V; Gupta R; Kumar U; Juyal RC; K TB
    Pharmacogenet Genomics; 2009 Oct; 19(10):823-8. PubMed ID: 19902562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacogenetic model to predict response of MTX monotherapy in patients with established rheumatoid arthritis after DMARD failure.
    Fransen J; Kooloos WM; Wessels JA; Huizinga TW; Guchelaar HJ; van Riel PL; Barrera P
    Pharmacogenomics; 2012 Jul; 13(9):1087-94. PubMed ID: 22838954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABCB1 C3435T polymorphism influences methotrexate sensitivity in rheumatoid arthritis patients.
    Takatori R; Takahashi KA; Tokunaga D; Hojo T; Fujioka M; Asano T; Hirata T; Kawahito Y; Satomi Y; Nishino H; Tanaka T; Hirota Y; Kubo T
    Clin Exp Rheumatol; 2006; 24(5):546-54. PubMed ID: 17181924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphisms in key methotrexate pathway genes are associated with response to treatment in rheumatoid arthritis patients.
    Owen SA; Hider SL; Martin P; Bruce IN; Barton A; Thomson W
    Pharmacogenomics J; 2013 Jun; 13(3):227-34. PubMed ID: 22450926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of methotrexate clinical response in Portuguese rheumatoid arthritis patients: implication of MTHFR rs1801133 and ATIC rs4673993 polymorphisms.
    Lima A; Monteiro J; Bernardes M; Sousa H; Azevedo R; Seabra V; Medeiros R
    Biomed Res Int; 2014; 2014():368681. PubMed ID: 24967362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis.
    Dervieux T; Furst D; Lein DO; Capps R; Smith K; Walsh M; Kremer J
    Arthritis Rheum; 2004 Sep; 50(9):2766-74. PubMed ID: 15457444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine Deaminase Gene Polymorphism and Baseline Serum Level of Adenosine Deaminase as a Biomarker of Response to Methotrexate in Rheumatoid Arthritis.
    Gangadharan H; Singh A; Majumder S; Aggarwal A
    J Clin Rheumatol; 2021 Dec; 27(8):e609-e611. PubMed ID: 33044386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of genetic variants of ATP binding cassette B1, AICAR transformylase/IMP cyclohydrolase, folyl-polyglutamatesynthetase, and methylenetetrahydrofolatereductase on methotrexate toxicity.
    Sala-Icardo L; Lamana A; Ortiz AM; García Lorenzo E; Moreno Fresneda P; García-Vicuña R; González-Álvaro I
    Reumatol Clin; 2017; 13(6):318-325. PubMed ID: 27751863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms and pharmacogenomics for the toxicity of methotrexate monotherapy in patients with rheumatoid arthritis: A systematic review and meta-analysis.
    Qiu Q; Huang J; Lin Y; Shu X; Fan H; Tu Z; Zhou Y; Xiao C
    Medicine (Baltimore); 2017 Mar; 96(11):e6337. PubMed ID: 28296761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between genetic variants in the adenosine pathway and outcome of methotrexate treatment in patients with recent-onset rheumatoid arthritis.
    Wessels JA; Kooloos WM; De Jonge R; De Vries-Bouwstra JK; Allaart CF; Linssen A; Collee G; De Sonnaville P; Lindemans J; Huizinga TW; Guchelaar HJ
    Arthritis Rheum; 2006 Sep; 54(9):2830-9. PubMed ID: 16947783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.